These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27298569)

  • 1. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.
    Jiang SM; Jia L; Liu J; Shi MM; Xu MZ
    World J Gastroenterol; 2016 Jun; 22(22):5260-6. PubMed ID: 27298569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss.
    Tack J; Ly HG; Carbone F; Vanheel H; Vanuytsel T; Holvoet L; Boeckxstaens G; Caenepeel P; Arts J; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):385-392.e4. PubMed ID: 26538208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression.
    Du HG; Ming L; Chen SJ; Li CD
    World J Gastroenterol; 2014 Nov; 20(44):16739-44. PubMed ID: 25469046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
    Schmid DA; Wichniak A; Uhr M; Ising M; Brunner H; Held K; Weikel JC; Sonntag A; Steiger A
    Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
    Bech P
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
    J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mirtazapine treatment on body composition and metabolism.
    Laimer M; Kramer-Reinstadler K; Rauchenzauner M; Lechner-Schoner T; Strauss R; Engl J; Deisenhammer EA; Hinterhuber H; Patsch JR; Ebenbichler CF
    J Clin Psychiatry; 2006 Mar; 67(3):421-4. PubMed ID: 16649829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between depression, weight loss and leptin/ghrelin levels in male patients with head and neck cancer undergoing radiotherapy.
    Ozsoy S; Besirli A; Unal D; Abdulrezzak U; Orhan O
    Gen Hosp Psychiatry; 2015; 37(1):31-5. PubMed ID: 25440723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
    Danileviciūte V; Sveikata A; Adomaitiene V; Gumbrevicius G; Fokas V; Sveikatiene R
    Medicina (Kaunas); 2009; 45(10):778-84. PubMed ID: 19996664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.